1 / 8
文档名称:

【医学课件】timiiiia研究课件.ppt

格式:ppt   大小:131KB   页数:8页
下载后只包含 1 个 PPT 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

文档介绍:IV Heparin, (ASA), Beta-blockers, Nitrates, Ca++ blockers
Randomize
Angio 18-36 hrs
t-PA
0.8 mg/kg over 90 mins
391 IV Heparin, (ASA), Beta-blockers, Nitrates, Ca++ blockers
Randomize
Angio 18-36 hrs
t-PA
0.8 mg/kg over 90 mins
391 Patients with Unstable Angina / NQWMI
Placebo
Primary Endpoint:
Death, MI,
Positive ETT 6 weeks
Follow-up 6 weeks
Circulation 1993;87:38-52
Baseline Angio
Angio Exclusion:
no CAD or LMain
TIMI IIIA
Protocol Design
: :// ;; :


Apparent thrombus
35%
Possible thrombus
30%
No thrombus
35%
Improvement in Culprit Lesion: 25% t-PA vs. 19% placebo p=NS
TIMI IIIA Investigators. Circulation 1993;87:38-52.
TIMI IIIA
Effects of tPA on Coronary Lesions
Primary Results
BASELINE ANGIORAPHY:
ANGIORAPHY AFTER tPA:

ASA, IV Heparin, Beta-blockers, Nitrates, Ca++ blockers
Randomize
ETT 6 weeks
Early Invasive:
Cath 18-48 h
PTCA/CABG prn
1473 Patients with Unstable Angina / NQWMI
Early Conservative:
ST Holter, ETT Thallium
Cath/PTCA if +ischemia
1o Endpoint Inv-Cons:
Death, MI,
Positive ETT - 6 weeks
Follow-up 1 year
Circulation 1994;89:1545-56
2x2 Factorial:
t-PA vs. Placebo
1o Endpoint t-PA:
Death, MI, Rec Isch,
+ ETT, Thallium
or ST Holter

TIMI IIIB
Protocol Design

TIMI IIIB Investigators. Circulation 1994;89:1545-56

TIMI IIIB
tPA vs. Placebo in Non-ST Elevation ACS
Primary Results
Composite Endpoint

分享好友

预览全文

【医学课件】timiiiia研究课件.ppt

上传人:AIOPIO 8/6/2022 文件大小:131 KB

下载得到文件列表

【医学课件】timiiiia研究课件.ppt

相关文档